PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

GPT Healthcare Limited

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from GPT Healthcare Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.

What stands out

  • Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: ₹4 per ₹100 of sales comes from others' credit, against ₹4 from others' credit three years earlier. Less money tied up than 93% of Healthcare companies in India.

Where ₹100 of sales goes

₹88Operating costs₹1.6Interest₹8.9Net profit₹4.3Paid as dividends

Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

₹155

Over the last 3 years, every ₹100 of reported profit came with ₹155 of operating cash.

Higher than 73% of Healthcare companies in India.

Self-Funding Ratio

2.0×

Over the last 3 years its own operating cash covered its investment spending (capex) 2.0 times.

Higher than 67% of Healthcare companies in India.

Cash Locked Ratio

−₹4

Money owed to suppliers is larger than money owed by customers plus stock: ₹4 per ₹100 of sales comes from others' credit, against ₹4 from others' credit three years earlier.

Less money tied up than 93% of Healthcare companies in India.

Growth quality

Steadiness Ratio

3/3 · 2/3

Sales grew in 3 of the last 3 years; profit grew in 2 of 3.

Steadier than 53% of Healthcare companies in India.

Growth Efficiency Ratio

₹3

Sales grew 32% in 3 years; of every extra ₹100 of sales, ₹3 became extra profit.

Lower than 82% of Healthcare companies in India.

Asset Productivity Ratio

+32% / +42%

In 3 years sales changed by +32% while total assets changed by +42%. Assets grew faster than sales.

Balance-sheet strength

Debt Due Cover Ratio

9.1×

Debt due within a year is covered 9.1 times by its yearly operating cash.

Higher than 75% of Healthcare companies in India.

Cash Cushion Ratio

−4%

Debt, after subtracting cash, equals 4% of its market value (net debt).

Lower than 62% of Healthcare companies in India.

Tangible Assets Ratio

100%

Of every ₹100 the company owns, ₹100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 81% of Healthcare companies in India.

Tangible Net Worth Ratio

100%

Of every ₹100 of net worth, ₹100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

More tangible than 79% of Healthcare companies in India.

Shareholders

Shareholder Slice Ratio

0%

Share count was unchanged over the last 3 years. Dividends paid equalled 52% of profit over the same period.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

GPT Healthcare Limited owes ₹0.42 for every ₹1 it owns. Net profit fell 15% in the year to Mar 2026, and grew 3% a year on average over 3 years.

Compared with Healthcare companies in India · latest annual results Mar 2026.

P/E ratio

23.2

Investors pay ₹23.2 for every ₹1 of GPT Healthcare Limited's yearly profit, lower than 77% of Healthcare companies in India.

P/B ratio

4.07

The share price is 4.07 times GPT Healthcare Limited's book value per share, lower than 58% of Healthcare companies in India.

Market cap

₹1,096 Cr

The total market value of all of GPT Healthcare Limited's shares at today's price (share price × number of shares), smaller than 78% of Healthcare companies in India. PosiCap size class: Mini Cap.

Net worth (book value)

₹269 Cr

What GPT Healthcare Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).

Book value per share

₹32.84

Net worth divided by the number of shares. The share price of ₹133.55 is 4.1 times this, which is the P/B above.

Return on equity (ROE)

17.5%

GPT Healthcare Limited earned 17.5% on its shareholders' money over the last year, higher than 72% of Healthcare companies in India.

Owes vs Owns

0.42×

GPT Healthcare Limited owes ₹0.42 for every ₹1 it owns (low), higher than 64% of Healthcare companies in India.

Dividend yield

2.15%

GPT Healthcare Limited pays 2.15% of its share price as dividends a year, higher than 94% of dividend-paying Healthcare companies in India.

Revenue growth

+16%

Revenue rose 16% in the year to Mar 2026, and grew 10% a year on average over 3 years.

Profit growth

-15%

Net profit fell 15% in the year to Mar 2026, and grew 3% a year on average over 3 years.

Profit margin

8.9%

GPT Healthcare Limited keeps ₹9 of every ₹100 of revenue as net profit.

Cash quality

1.9×

Cash from GPT Healthcare Limited's business was 1.9× its reported profit in the year to Mar 2026 — its profit turned into cash.

Interest cover

7.8×

GPT Healthcare Limited's operating profit covered its interest costs 7.8 times in the year to Mar 2026.

Cash vs debt

Net debt

GPT Healthcare Limited had ₹44 Cr more debt than cash (net debt) at Mar 2026.

Questions

What is GPT Healthcare Limited's P/E ratio?

Investors pay ₹23.2 for every ₹1 of GPT Healthcare Limited's yearly profit, lower than 77% of Healthcare companies in India.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For GPT Healthcare Limited: ₹1,096 Cr ÷ ₹269 Cr (31 Mar 2026) = 4.1.

What is GPT Healthcare Limited's return on equity?

GPT Healthcare Limited earned 17.5% on its shareholders' money over the last year, higher than 72% of Healthcare companies in India.

How much does GPT Healthcare Limited owe compared with what it owns?

GPT Healthcare Limited owes ₹0.42 for every ₹1 it owns (low), higher than 64% of Healthcare companies in India.

Does GPT Healthcare Limited pay a dividend?

Yes. GPT Healthcare Limited pays 2.15% of its share price as dividends a year, higher than 94% of dividend-paying Healthcare companies in India.

Is GPT Healthcare Limited's revenue growing?

Revenue rose 16% in the year to Mar 2026, and grew 10% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.